|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2004-4-13
|
|
pubmed:abstractText |
Circulating endothelial progenitor cells (EPCs) have been reported previously. In this study, we examined the hypothesis that overexpression of vasculoprotective gene endothelial nitric oxide synthase (eNOS) and heme oxygenase-1 (HO-1) in EPCs enhances their ability to inhibit neointimal hyperplasia.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Complementary,
http://linkedlifedata.com/resource/pubmed/chemical/Green Fluorescent Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/HMOX1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Heme Oxygenase (Decyclizing),
http://linkedlifedata.com/resource/pubmed/chemical/Heme Oxygenase-1,
http://linkedlifedata.com/resource/pubmed/chemical/Luminescent Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/NOS3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type III,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
13
|
|
pubmed:volume |
109
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1769-75
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:15066951-Angioplasty, Balloon,
pubmed-meshheading:15066951-Animals,
pubmed-meshheading:15066951-Carotid Artery, Common,
pubmed-meshheading:15066951-Carotid Artery Injuries,
pubmed-meshheading:15066951-Cells, Cultured,
pubmed-meshheading:15066951-DNA, Complementary,
pubmed-meshheading:15066951-Endothelial Cells,
pubmed-meshheading:15066951-Endothelium, Vascular,
pubmed-meshheading:15066951-Enzyme Induction,
pubmed-meshheading:15066951-Gene Therapy,
pubmed-meshheading:15066951-Genes, Reporter,
pubmed-meshheading:15066951-Genetic Vectors,
pubmed-meshheading:15066951-Green Fluorescent Proteins,
pubmed-meshheading:15066951-Heme Oxygenase (Decyclizing),
pubmed-meshheading:15066951-Heme Oxygenase-1,
pubmed-meshheading:15066951-Humans,
pubmed-meshheading:15066951-Hyperplasia,
pubmed-meshheading:15066951-Luminescent Proteins,
pubmed-meshheading:15066951-Male,
pubmed-meshheading:15066951-Membrane Proteins,
pubmed-meshheading:15066951-Nitric Oxide Synthase,
pubmed-meshheading:15066951-Nitric Oxide Synthase Type III,
pubmed-meshheading:15066951-RNA, Messenger,
pubmed-meshheading:15066951-Rabbits,
pubmed-meshheading:15066951-Recombinant Fusion Proteins,
pubmed-meshheading:15066951-Retroviridae,
pubmed-meshheading:15066951-Thrombosis,
pubmed-meshheading:15066951-Transduction, Genetic,
pubmed-meshheading:15066951-Tunica Intima
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells.
|
|
pubmed:affiliation |
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02115, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
